Back to Search
Start Over
Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia
- Source :
- Blood Advances
- Publication Year :
- 2022
- Publisher :
- American Society of Hematology, 2022.
- Subjects :
- 2019-20 coronavirus outbreak
COVID-19 Vaccines
Coronavirus disease 2019 (COVID-19)
COVID-19 Vaccine
Chronic lymphocytic leukemia
Antibodies, Viral
Persistence (computer science)
Research Letter
medicine
Humans
In patient
RNA, Messenger
BNT162 Vaccine
Messenger RNA
biology
SARS-CoV-2
business.industry
Vaccination
COVID-19
antibody response
persistence
Hematology
medicine.disease
Leukemia, Lymphocytic, Chronic, B-Cell
Immunology
biology.protein
BNT162b2
Antibody
business
CLL
Subjects
Details
- ISSN :
- 24739537 and 24739529
- Volume :
- 6
- Database :
- OpenAIRE
- Journal :
- Blood Advances
- Accession number :
- edsair.doi.dedup.....490e8bf68efd6cf720bbd3262773b75c